Facit | Cancer Breakthroughs Realized
Facit | Cancer Breakthroughs Realized
  • About
    • About FACIT
    • Our Network
    • Leadership
    • Careers
    • Contact
  • Portfolio
  • Funds
    • Funds & Programs Overview
      • Prospects
      • Compass Rose
      • WeSEED
  • Falcons’ Fortunes
    • Event Info & RSVP
    • Pitch Competition – apply
  • News
Normal High
Text Size:

Portfolio Category: Prospects

FACIT-27 | OICR (self-adjuvanting vaccines, Dr. R. Al-awar)

October 5, 2021 –

Read More from FACIT-27 | OICR (self-adjuvanting vaccines, Dr. R. Al-awar)

FACIT-32 | Pattern Pharma (formerly Realist Pharma)

October 5, 2021 –

Read More from FACIT-32 | Pattern Pharma (formerly Realist Pharma)

FACIT-34 | Queen’s University (CYP26 inhibitors, Dr. M. Petkovich)

October 5, 2021 –

Read More from FACIT-34 | Queen’s University (CYP26 inhibitors, Dr. M. Petkovich)

FACIT-35 | 16-Bit

October 5, 2021 –

Read More from FACIT-35 | 16-Bit

Posts navigation

  • «
  • 1
  • …
  • 3
  • 4
  • 5
  • Privacy Policy
  • Accessibility
  • Terms & Conditions
  • Reporting Improper Activities

FACIT
MaRS Centre
661 University Ave., Suite 510
Toronto, Ontario, Canada M5G 0A3

E: info (at) facit.ca